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In vivo administration in mice of a synthetic analog of prostaglandin E2 (PGE2) caused a
selective and dramatic decrease of CD4+CD8 double-positive, CD3/T-cell-receptor-ccb
1
cells in the thymus. This loss was corticosteroid-independent and not affected by
Cyclosporin A. The disappearance of CD4+CD8 thymocytes was strictly correlated with
the induction of apoptosis inside the thymus as shown by morphological studies and by
the induction of intracellular transglutaminase expression. Considering that PGE2 has
been found to be produced by different cell populations inside the thymus, these results
indicate that PGE2 may act as endogenous signals for apoptosis during T-cell
differentiation.
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INTRODUCTION
It is generally acknowledged that prostaglandin
E2 (PGE2) exerts a powerful modulatory action on
mature T cells (Goodwin, 1985; Vercammen and
Ceuppens, 1987; Betz and Fox, 1991). Conversely,
little information exists on its effects in the course
of T-cell differentiation (Rinaldi-Garaci et al.,
1983). The programmed cell death (PCD)of thy-
mocytes is considered to be a crucial event that
occurs during the intrathymic phase of T-cell dif-
ferentiation. This death of physiological signifi-
cance occurs in tissues by an active cellular
phenomenon of self-destruction, called
"apoptosis." It requires coordinate expression of
regulatory proteins, as bc12, and enzymes, as
Ca++/Mg+/-dependent endonuclease and tissue
transglutaminase (tTG), causing morphological
modifications of the cell and leading to a final
irreversible damage of DNA, characterized by
molecule fragmentation (Wyllie et al., 1980;
Arends and Wyllie, 1991; Piacentini et al., 1991a,
1991b). Apoptosis would lead to the controlled
removal of thymocytes, during both positive and
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negative selection of functionally mature T cells
(Rothemberg, 1990; Boyd and Hugo, 1991; von
Boehmer, 1991; Zugic, 1991). The intrinsic mech-
anisms and the biochemical mediators of PCD in
thymocytes in vivo are not yet clear (McConkey
et al., 1990b). Moreover it is difficult to under-
stand how T-cell-receptor (TCR)-mediated sig-
nals could result in two distinct thymocyte fates,
that is, protection from PCD in the case of posi-
tive selection or induction of PCD in the case of
negative selection. Recently, it has been demon-
strated that an intracellular increase of cAMP
stimulates PCD in rat and mouse thymocytes in
vitro (McConkey et al., 1990a; Suzuki et al., 1991).
Here we report the evidence that administration
in mice of a synthetic analog of PGE2, 16,16-
dimethyl-PGE2 methyl ester (DI-M-PGE2),
induces apoptosis of thymocytes in vivo, and that
thymocytes at phenotypically different stages of
differentiation show variable sensitivity to PGE2.
RESULTS
Effects of PGE2 Administration on
Phenotypically Identified Thymocyte Subsets
DI-M-PGE2, a long-acting synthetic analog of
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PGE2, was administered i.p. into adult C57BL/6
mice at different doses in a single daily injection
for a time ranging from 1 to 8 consecutive days.
Thymuses were then collected and thymocytes
were analyzed by flow cytometry using specific
monoclonal antibodies. Results showed a dra-
matic and selective depletion of CD4/CD8
/ cells.
The effect was directly dependent on the dose,
the number of the injections, and the time after
the administration, with a maximum reached
12 hr after the last of four injections at the dose of
1 mg/kg/day (Figs. 1A to 1D). The prolongation
of the treatment did not lead to further modifi-
catioias. Regarding the expression of CD3 and
TCR-o]/ molecules, thymocytes can be subdiv-
ided into negative cells and into low (lo), inter-
mediate (int), and high (hi) expressing cells, cor-
responding to successive stages of T-cell
differentiation (Ohashi et al., 1990). Dose-effect
experiments demonstrated that CD3/TCR-o]/lo
cells were the most sensitive to DI-M-PGE2
action, followed by CD3/TCR-oJ int, and nega-
tive cells (Figs. 1E to 1L). Conversely, CD3/TCR-
ccf hi, CD4/, or CD8
/ single-positive thymocytes,
expressing a "mature" phenotype, were highly
resistant to DI-M-PGE2. Looking at absolute
numbers of thymocytes, a fall in all subsets in
mice treated with DI-M-PGE2 was observed, with
the most dramatic change noted in the CD4/CD8+
cells. This was related to a decrease of thymus
total cellularity after PGE2 treatment (control
diluent=l.0xl08+0.1xl08 cells, mean+SD, n=6; DI-
M-PGE2=l.6x107+2.0x106 cells, n=3, dosage=
1 mg/kg/dayx4). The effect was reversible, as
demonstrated by a good and progressive recov-
ery of all subsets, which followed stopping
treatment.
Effect of PGE2 Administration on Tissue
Transglutaminase Levels and on Morphological
Features of Apoptosis in the Thymus
No evidence for a migration of CD4/CD8+ cells to
peripheral lymphoid organs, after PGE2 adminis-
tration, as detected by flow cytometry at spleen
and lymphonode level, was observed. We have
then investigated if the disappearance of
CD4+CD8/, CD3/TCR-o]/lo, and thymocytes after
DI-M-PGE2 administration could be related to the
intrathymic PCD of thymocytes that naturally
occurs, particularly in cortical CD4+CD8
/ thymo-
cytes, during T-cell differentiation. Recently, in
vitro and in vivo experiments have clearly dem-
onstrated that apoptotic cells, both of normal and
neoplastic origin, specifically express high levels
of tTG (Fesus et al., 1987, 1989; Arends and
Wyllie, 1991; Piacentini et al., 1991a, 1991b). By
contrast, the enzyme expression is not enhanced
during necrosis (Fesus et al., 1987). tTG, by catal-
izing covalent cross links between polypeptide
chains, leads to the assembly of a stable protein
scaffold (insoluble in detergents and chaotropic
agents) that prevents the release of harmful mol-
ecules from the dying cell before its final degra-
dation by phagocitosis (Fesus et al., 1989). The
induction of tTG could so be considered as an
early event during apoptosis. On the basis of
these findings, we monitored the expression of
tTG, in parallel with the morphology of thymus
cells, in order to characterize apoptosis after DI-
M-PGE2 in vivo administration. Upon a single
DI-M-PGE2 injection, tTG activity was increased
over the controls as early as 3 hr, reaching a two-
fold increase at 24 hr. Repeated treatments had
additive effects in enhancing the enzyme activity
(Table 1). The effect of PGE2 was limited to the
thymus, as indicated by the absence of induction
of tTG in other organs, such as spleen (control=
0.75+0.04nmol/hr/mg protein, mean+SD, n=3;
DI-M-PGE2=0.35+0.06 nmol/hr/mg protein, n=3)
or liver (control=0.62+0.05 nmol/hr/mg protein,
n=3; DI-M-PGE2=0.45+0.08 nmol/hr/mg protein,
n=3). Immunohistochemical analysis of thymus
TABLE
Tissue Transglutaminase (tTG) Activity of Thymuses from
DI-M-PGE2 Treated Mice
Treatment tTG activity
(% of control)
Time after
last injection
(hr)
No. of
injections
(once a day)
3 150+12
12 183_+41
24 198_+35
48 161+30
72 155+24
2 3 298_+52
3 3 315+48
4 3 277_+36
2 24 212+37
3 24 225+45
4 24 214_+30
aTransglutaminase activity measured by detecting the incorporation of
(3H)putrescine into N,N’-dimethylcasein and calculated nanomoles of
(3H)putrescine incorporated into protein per hour, expressed percentage from
values obtained in mice treated with control diluent (0.24+0.08nmol/hr/mg
protein). Data the cumulative means+SD of triplicate determinations of each
individual thymus, derived from five different experiments (total n=30 for each
experimental group).PROSTAGLANDIN E2 AND THYMOCYTE APOPTOSIS 265
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FIGURE 1. PGE2 in vivo adminis-
tration causes the selective loss of
CD4/CD8 and CD3/TCR-a]/lo thy-
mocytes. C57BL/6NCr BR male
mice were injected i.p. with control
diluent (A, E, I) or 16,16-dimethyl
prostaglandin E2 (Di-M-PGE2) at
doses of 0.25mg/kg (B and F),
0.5 mg/kg (C and G), and mg/kg
(D, H, and L) once a day for 4 con-
secutive days. Immunofluorescence
staining and flow cytometry analy-
sis were performed 12 hr after the
last injection. The following anti-
bodies were utilized: phycoerythrin
conjugate antimouse L3T4 and flu-
orescein conjugate antimouse Lyt-2
for a two-color analysis of CD4
(vertical axis) and CD8 (horizontal
axis) positive cells, respectively (A
to D); fluorescein conjugate anti-
CD3- for a single-color analysis (E to
H); fluorescein conjugate anti-a]/
TCR (H57-597 mAb) for a single-
color analysis (I and L). In single-
color analysis, cell numbers (same
full scale) are represented in the ver-
tical axis and fluorescence, on the
logarithmic scale, was plotted on
the horizontal axis. The dashed lines
in two-color analysis (A to D) indi-
cate quadrant boundaries obtained
by limiting 99.8% of the background
events in the lower-left quadrant.
The dashed lines in single-color
analysis (E to L) indicate the upper
and lower boundaries of CD3/TCR-
a]/lo, int, or hi populations for com-
parison among treatment groups.
The first boundary was obtained by
limiting 99.7%. of the background
events, and the others were set arbi-
trarily on the basis of the curve pro-
file obtained in control samples.
Numbers in the cytographs indicate
percentages of cells within markers.
The experiment was repeated six (A
to D) and three (E to L) times, using
three mice for each experimental
group, with similar results within
groups.266 A. MASTINO et al.
TABLE 2
Effect of PGE2 Administration on CD4- and CD8-Identified Thymocytes in Adrenalectomized Mice
Group Treatment Percent of total (mean+SD)
CD4-CD8- CD4+CD8 CD4/CD8 CD4-CD8
None 1.6+0.6 83.5+1.0 10.0+1.0 4.7+0.6
2 Di-M-PGE2 4.3+1.2 55.6+13.0 30.9+7.3 9.2+4.5
3 Adrenalectomy 1.2+0.6 79.3+2.8 11.6+1.8 7.9_-b0.4
4 Adrenalectomy plus Di-M-PGE2 6.2+1.4f’g 54.9+7.3f’h 27.1+3.9f’g 11.8+2.0f’i
aNormal adrenalectomized mice injected with Di-M-PGE2 at dose of 0.25 mg/kg/day for 4 consecutive days (groups and 4, respectively). Twenty-four hours
after the last injection, thymuses collected and flow cytometry analysis of thymocyte subsets performed. Untreated (group 1) adrenalectomized (group 3), sex,
and age matched controls also tested. Results represent percentage valtaes+standard deviation obtained from three mice individually tested. Statistical analysis
performed by Student’s t-test.
bp<0.05 against corresponding value of group 1.
cP<0.01 against corresponding value of group 1.
aN.S. against corresponding value of group 1.
eP<0.005 against corresponding value of group 1.
fN.S. against corresponding value of group 2.
gP<0.005 against corresponding value of group 3.
hp<0.01 against corresponding value of group 3.
ip<0.05 against corresponding value of group 3.
after DI-M-PGE2 administration showed a large
induction of tTG protein in several cells mainly
localized in the thymus cortex (Figs. 2A to 2C).
The morphology of positive cells showed the dis-
tinctive features of apoptosis (condensed
chromatin and nuclear fragmentation) that
appeared unequivocal when the immunostaining
was performed in single-cell suspensions of thy-
mocytes freshly isolated from DI-M-PGE2 treated
mice (Fig. 2D).
Effect of PGE2 Administration on CD4- and
CD8-Identified Thy,mocytes in
Adrenalectomized Mice
Considering that a cell loss of CD4/CD8
/ thymo-
cytes, similar to that observed by us after DI-M-
PGE2 treatment, is also induced in vivo by gluco-
corticoids (Screpanti et al., 1989), we have inves-
tigated if the elimination of CD4/CD8+ thymo-
cytes caused by PGE2 could be mediated by
endogenous steroid production. In fact, it is
known that glucocorticoids induce apoptosis of
thymocytes (Wyllie et al., 1980; Wyllie and
Morris, 1982; Ojeda et al., 1990). Therefore, we
have repeated the experiments in adrenalecto-
mized mice. After 4 days of treatment at the dose
of 0.25 mg/kg/day (the maximal tolerated dose
of DI-M-PGE2 by adrenalectomized mice), DI-M-
PGE2 administration resulted in a cell loss of
CD4/CD8+ thymocytes, with respect to untreated
controls, that was similar in intact as well as in
adrenalectomized mice (Table 2). Thus, it is
reasonable to hypothesize that PGE2 action on
thymocytes is not mediated by endogenous
corticosteroids.
Effect of PGE2 Administration on CD4- and
CD8-Identified Thymocytes in Cyclosporin
A-Treated Mice
It has been previously reported that apoptosis of
thymocytes induced in vivo by anti-CD3 anti-
bodies can be inhibited by Cyclosporin A (CsA)
(Shi et al., 1989). In order to verify an eventual
relationship between apoptosis induced in vivo
FIGURE 2 Immunolocalization of tTG protein in mouse thymus and freshly isolated thymocytes. Immunostaining both on
paraffin included thymus sections and freshly isolated thymocytes was performed 3 hr after the last DI-M-PGE2 injection using an
affinity-purified monospecific rabbit IgG against soluble "tissue transglutaminase." Biotinylated goat antirabbit IgG was used as
second antibody followed by a preformed avidin-horseradish peroxidase complex. Cells were counterstained in Mayer’s
hemalum. In thymus from control animals, the positivity to the anti-tTG antibody is limited to the endothelial cells lining the
vessels (A). On the contrary, note the presence in the thymus cortex of many immunopositive (arrows) presumptive preapoptotic
thymocyte after PGE2 administration (B); Bar=60/ria. Higher magnification of the thymus cortex from PGE2-treated animals (C);
Bar=12/m. Intense positivity to anti-tTG antibody is localized in cells showing a picknotic nucleus (arrows). Isolated thymocytes.
After extensive washing in PBS, cells were smeared on slides, fixed in 2.5% paraformaldehyde, and, after immunostaining,
counterstained with Mayer’s henaalum. In thymocytes from control mice, no positive reaction was observed (data not shown); in
cells isolated from PGE2-treated animals, an increase in tTG protein expression is observed (D); Bar=60/m. Note the intense
staining of shrinked cells showing the condensed chromatin marginated at the cell periphery typical of apoptotic bodies (inset,
Bar=12/m). High concordant results were obtained in three independent experiments. (See Colour Plate VII at the back of this
publication).268 A. MASTINO et al.
by anti-CD3 antibodies and that induced by DI-
M-PGE2, we have investigated the effects of a
simultaneous administration of PGE2 and CsA.
The flow cytometry analysis performed 24hr
after the last treatment did not show any differ-
ence between the cell loss of CD4/CD8+ thymo-
cytes in mice treated with DI-M-PGE2 alone and
those treated with DI-M-PGE2 plus CsA (Table 3).
In addition, no changes in tTG activity were
observed (data not shown).
DISCUSSION
A restricted number of experimental models of
induction of thymocyte apoptosis has so far been
described. In fact, apoptosis of thymocytes has
been unequivocally proved to be induced in vitro
by glucocorticoids (Wyllie et al., 1980; Wyllie and
Morris, 1982; Ojeda et al., 1990), radiations
(Yamada and Ohyama, 1988), calcium iono-
phores and phorbol ester (Kizaki et al., 1989), or
in vitro as well as in vivo by anti-CD3 antibodies
(Shi et al., 1989; Smith et al., 1989) and some pep-
tide antigens (Jenkinson et al., 1989; Murphy et
al., 1990). Our results provide the first direct evi-
dence for a pharmacological induction of thymo-
cyte apoptosis in vivo. In fact, it is described by a
simple and highly reproducible pharmacological
experimental model of thymocyte apoptosis in
vivo. Moreover, thd recently obtained evidence
for the induction of thymocyte apoptosis in vitro
by PGE2 and other intracellular cAMP elevating
agents (McConkey et al., 1990a; Suzuki et al.,
1991) furnishes a clear in vitro experimental
support to the observation we have obtained in
vivo. The in vivo PGE2-induced PCD includes
pecularities that extend and clarify the pre-
viously described thymocyte apoptosis features.
In fact, it is not mediated by endogenous gluco-
corticoids, nor inhibited by CsA as in vivo CD3-
induced PCD. Indeed, glucocorticoids seem not
to be produced inside the thymus, nor could
radiations or anti-CD3 antibodies constitute
physiological triggers for thymocyte apoptosis.
On the contrary, PGE2 are produced in large
amounts inside the thymus by a wide variety of
cell types as thymic epithelial cells, dendritic
cells, macrophages (Gallily et al., 1985; Homo-
Delarche, 1985; Nieburgs et al., 1985), and also
nurse cells as recently reported (McCormack et
al., 1991). Interestingly, a selective elimination of
double-positive immature thymocytes by a thy-
mic epithelial cell line has been reported in vitro
(Nakashima et al., 1990); on the other hand, it has
been recently demonstrated that thymic macro-
phages or dendritic cells are associated to differ-
ent subsets of developing thymocytes, suggesting
a role for thymic rosettes, consisting of thymo-
cytes attached to a central stromal cell, in the
maturation steps in the thymic cortex (Shortman
and Vremec, 1991). Thus, it is possible that PGE2,
endogenously produced by stromal cells inside
the thymus during the intercellular contacts,
which seem to play an important role during T-
cell development, could locally reach concen-
trations active to induce cell death of thymocytes
by apoptosis. The different sensitivity of
CD3/TCR-c]/lo, CD3/TCR-c]/int, or CD3/TCR-
c]/hi, thymocytes to PGE2, could be involved in
TABLE 3
Effect of PGE2 ADministration on CD4- and CD8-Identified Thymocytes in Cyclosporin-A-Treated Mice
Group Treatment Percent of total (mean+_SD)
CD4-CD8- CD4/CD8 CD4/CD8 CD4-CD8
1 None 1.2+0.8 87.7+1.1 13.1+1.0 4.0+0.7
2 Di-M-PGE2 3.9+1.2 39.6+9.7 37.1+9.7 19.4+4.1
3 Cyclosporin A 1.4+0.4 82.8+2.2 11.4+1.8 4.4+0.6
4 Cyclosporin A 6.1+1.6f’g 41.6+6.9f’h 32.2+2.8f’h 20.1_2.5f’h
plus Di-M-PGE2
aMice injected with: Di-M-PGE2 at dose of 0.5 mg/kg/day for 4 consecutive days (group 2); Cyclosporin A at dose of 50 mg/kg/day for 4 consecutive days (group
3); both Di-M-PGE2 plus CsA (group 4). Twenty-four hours after the last injection, thymuses collected and flow cytometry analysis of thymocyte subsets
performed. A group of and age-matched controls also tested (group 1). Results represent percentage values+/-standard deviation obtained from three mice
individually tested. Statistical analysis performed by Student’s t-test.
bp<0.05 against corresponding value of group 1.
cp<0.005 against corresponding value of,group 1.
alP<0.001 against corresponding value of group 1.
eN.S. against corresponding value of group 1.
fN.S. against corresponding value of group 2.
gP<0.01 against corresponding value of group 3.
hp<0.001 against corresponding value of group 3.PROSTAGLANDIN E2 AND THYMOCYTE APOPTOSIS 269
the mechanism that leads to opposite final events
(selection or removal by PCD) in different phases
of T-cell differentiation. Our results could con-
tribute to explain the mechanism involved in the
physiological elimination of the majority of thy-
mocytes at the CD4+CD8
/ stage. A very rapid
clearance by macrophages of apoptotic thymo-
cytes could result in the difficulty to identify well
the physiologically occurring phenomenon. On
the other hand, the effects caused byPGE2, at the
pharmacological doses we have used, could over-
come the capacity of phagocytic cells to eliminate
dying cells, thus rendering the phenomenon as
evident when using an early marker of apoptosis
as tTG.
MATERIALS AND METHODS
Animals
Male C57BL/6NCrBR, 4-week-old mice, pur-
chased from Charles River Italia (Como, Italy),
and male C57BL/6J, 6-week-old adrenalecto-
mized or sham-adrenalectomized mice, pur-
chased from Nossan (Milan, Italy), were used.
Drugs and Treatment
Prostaglandin
Mice were injected i.p. with 16,16-dimethyl pro-
staglandin E2 (Di-M-PGE2) (Cayman Chem. Co.,
Ann Arbor, MI) at the doses of 0.25 mg/kg body
weight, 0.5 mg/kg, and 1 mg/kg once a day for a
time ranging from I to 4 consecutive days.
Immunofluorescence staining and flow cyto-
metry analysis were then performed. The follow-
ing antibodies were utilized: phycoerythrin con-
jugate antimouse L3T4 and fluorescein conjugate
antimouse Lyt-2 (Becton Dickinson, Mountain
View, CA) for a two-colors analysis of CD4- and
CD8-positive cells, respectively; fluorescein con-
jugate anti-CD3-e (clone 145-2Cll) (Boehringer
Mannheim Bioch., Mannheim, Germany) for a
single-color analysis; fluorescein conjugate
anti-aft TCR (H57-597 mAb), kindly provided by
L. Jones (NCI, NIH, Bethesda), for a single-color
analysis. Phycoerythrin conjugate antihuman
CD4 and fluorescein conjugated antihuman CD8
(Becton Dickinson) were used as unrelated con-
trols for background detecting. Staining was per-
formed at 4C for 30 min. After treatment, cells
were washed twice in PBS containing 0.02%
sodium azide and flow cytometry analysis was
performed using a FACScan (Becton Dickinson).
In two-color analysis, marks were set to indicate
quadrant boundaries limiting 99.8% of the back-
ground events in the lower left quadrant. In
single-color analysis, markers were set to indi-
cate the upper and lower boundaries of
CD3/TCR-ofl lo, int, or hi populations for com-
parison among treatment groups. The first
boundary was obtained by limiting 99.7% of the
background events, and the others were set arbi-
trarily on the basis of the curve profile obtained
in control samples and maintained in the exper-
imental samples. Data collection was gated on
live thymocytes by forward and side angle scat-
ter, utilized to exclude dead cells, debris, very
large nonlymphoid cells, and cell aggregates.
Data represent 5000 events.
Cyclosporin A
CsA (Sandoz, Basel, Switzerland) was adminis-
tered at the dose of 50 mg/kg of body weight,
daily for 4 consecutive days, alone or immedi-
ately after Di-M-PGE2 administration.
Immunofluorescence Staining and Flow
Cytometry Analysis
Thymuses were individually processed 12hr
after the last injection by gentle teasing in RPMI
1640. The resultant cell suspension was filtered
through a nytex mesh, washed twice with RPMI
1640, and resuspended in PBS at 2x107/ml cells.
Immunocytohistochemistry
Immunostaining on paraffin included thymus
sections and freshly isolated thymocytes was per-
formed 3 hr after the last DI-M-PGE2 injection
using as primary antibody (diluted 1:100) an
affinity-purified monospecific rabbit IgG raised
against soluble "tissue transglutaminase" of
human red blood cells (kindly furnished by L.
Fesus, University Medical School of Decebren,
Hungary) in a wet chamber overnight at 4 C.
Biotinylated goat antirabbit IgG was used as a
second antibody followed by a preformed
avidin-horseradish peroxidase complex
(Immunon, Detroit, MI). The reaction was devel-270 A. MASTINO et al.
oped using aminoethylcarbazole as chromogen
substrate and 0.01% H202. Cells were counter-
stained in Mayer’s hemalum. Endogenous per-
oxidase activity was blocked by methanol-H202.
Isolated thymocytes were obtained as previously
described for flow cytometry analysis. After
extensive washing in PBS, cells were smeared on
slides, then fixed in 2.5% paraformaldehyde and,
after immunostaining, counterstained with May-
er’s hemalum.
Tissue Transglutaminase Activity
Thymuses were collected from control or Di-M-
PGE2, at various time intervals after PGE2 admin-
istration, extensively washed in PBS, and homo-
genized in 0.1-M Tris-HC1, pH 7.5, containing
0.25-M sucrose, 0.5-mM EDTA, and 1-mM PMSF.
Transglutaminase activity was measured by
detecting the incorporation of (3H)putrescine into
N,N’-dimethylcasein. The incubation mixture
contained 150-mM Tris-HC1 buffer, pH 8.3, 5-mM
CaCI2, 10-mM dithiothreitol, 30-mM NaC1, 2.5-
mg N,N’-dimethylcasein/ml, 0.2-mM putrescine,
containing 1-mCi (3H)putrescine, and 0.1-0.2-mg
protein in a final volume of 0.3 ml. After 20 min
of incubation, the mixture was spotted onto
Whatman 3 mm filter paper moistened with 20%
trichloroacetic acid (TCA). Free (3H)putrescine
was eliminated by ’washing with large volumes
of cold 5% TCA containing 0.2-M KC1 before
counting, tTG activity was calculated as nano-
moles of (3H)putrescince incorporated into pro-
tein per hour, and was expressed as a percentage
from values obtained in mice treated with control
diluent.
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